Background: Women have unfavorable prognosis after myocardial infarction (MI). This text describes sex differences in mortality and in the power of risk predictors in contemporarily-treated MI patients. Methods: A population of 4141 MI patients (26.5% females) was followed up for 5 years. Effects of sex and age on total mortality were investigated by multivariable Cox analysis. Mortality predictors were investigated by receiver-operator characteristics analysis. Stepwise multivariable Cox regression was used to create sex-specific predictive models. Results: Thirty-day mortality was 1.5-fold higher in women. However, sex was not a significant mortality predictor in a model adjusted for age. Predictors for 5-year mortality performed differently in male and female patients. In women, a sex-specific model provided better risk stratification than a sex-neutral model. Conclusion: The unfavorable prognosis of female MI patients can be explained by advanced age. Sex-specific predictive models might improve risk stratification in female survivors of acute MI.
Introduction
Myocardial infarction (MI) is a major cause of morbidity and mortality in the developed world [1, 2] . The mortality risk in women suffering from MI is higher than that in men [3] . One obvious explanation for this disparity is that on average, women are about 10 years older than men at the time of MI. Other factors, such as gender bias in clinical approach to MI treatment [4] , inadequate MI diagnosis in women due to atypical presentation [5] , and lower rate of revascularization procedures in women [6] have also been discussed to explain the unfavorable outcome of MI in women.
Sex differences in the physiology of coronary artery disease (CAD), such as a higher prevalence of non-obstructive CAD in women [7] , may also contribute to the outcome differences. Furthermore, interventional treatments recommended by the guidelines [1, 2, 8, 9] might be less effective in females than in males due to the smaller diameter of the coronary arteries in the former [10] .
Patients surviving the acute MI phase are at risk of subsequent death due to re-infarction, arrhythmia, or heart failure. Corresponding non-invasive risk predictors are presently intensively researched [11] . While left-ventricular ejection fraction remains the core of current post-MI risk assessment, its limits are well recognized and several other parameters have been evaluated for their potential to improve risk stratification [11] [12] [13] [14] [15] [16] [17] [18] . A systematic analysis of sex differences in the predictive power of these parameters has not yet been reported.
This study re-assessed the mortality risk in contemporarilytreated MI patients of either sex and investigated whether the risk prediction in acute MI survivors might be improved by sexspecific predictive models.
Methods

Study cohort
The present study used data of patients enrolled in two separate cohort studies, namely the ISAR study [19] and the ART study [20] . Enrolment took place between January 1996 and March 2005 with last follow-up in May 2010. Patients were recruited at two centers in Munich (Klinikum rechts der Isar and Deutsches Herzzentrum München). We included patients suffering from acute MI within 4 weeks before enrolment. MI diagnosis was defined as two or more of (i) chest pain for ≥20 min, (ii) creatine kinase-MB above the doubled upper normal limit of our laboratory, (iii) ST-segment elevation of 0.1 mV in two or more limb leads and/or 0.2 mV in two or more contiguous precordial leads at the time of hospital admission. In the present analysis, we have not applied any upper age limit and also included patients who were not in sinus rhythm.
The study consisted of two parts, dealing with sex differences in the outcome (part A), and sex differences in the power of risk predictors (part B). Fig. 1 shows the patient flow. Part A involved all patients admitted to the hospital with acute MI (cohort A), whereas part B included only patients who (1) survived the first month after admission, (2) had no indication for secondary prevention implantable cardioverter/defibrillator (ICD) therapy, and (3) had a Holter ECG available (cohort B).
For parts A and B, the primary endpoint was all-cause mortality at 30 days and at 5 years, respectively.
The study was approved by the local ethics committee. Oral (ISAR study) or written (ART study) informed consent was obtained from all patients or from their legal caregivers.
Clinical variables
At admission, a standard 12-lead ECG was recorded and blood pressure, heart rate, serum creatinine and cardiac enzymes were measured in all patients. Left ventricular ejection fraction (LVEF) was quantified either by angiography or by echocardiography. Patients were considered to have diabetes if already diagnosed or if receiving treatment with diet, oral medication or insulin or if fasting blood glucose concentration repeatedly exceeded 11 mmol/L.
Holter and ECG variables
Holter ECGs were recorded during the initial hospitalization for MI using equipment by Oxford instruments (n = 829, 3 channels), Reynolds Medical (n = 1925, 3 channels), and Mortara Instrument (n = 197, 12 channels). The recordings were automatically analyzed by corresponding analytical systems. Subsequently, visual verification and, where appropriate, manual correction was made of QRS detections and classifications (normal, ventricular ectopic, and supraventricular ectopic) by experienced technicians.
Risk predictors derived from the Holter ECG included mean heart rate, number of ventricular premature complexes (VPCs) per hour, heart rate variability triangular index (HRVTI) [12] , heart rate turbulence [21] slope (TS) and onset (TO), heart rate deceleration capacity (DC) [22] , and Holter-derived nocturnal respiratory rate [16, 17] . QRS width and corrected QT interval (QTc; calculated according Bazett's formula) were obtained from a standard 12-lead ECGs.
Follow-up and endpoints
Clinical follow-up appointments were scheduled approximately every 6 months. If a patient did not attend a planned appointment, contact was made via mail, telephone or through the attending general practitioner. If none of these channels were successful, the local population registry either provided a new address of the patient or confirmed that the patient was deceased. If a patient could neither be contacted nor his/her death confirmed during the first year of follow-up, he/she was considered lost to follow-up. If this happened later in followup, the patient was censored at the time of last contact.
Statistics
Continuous variables are presented as median and interquartile range (IQR). Categorical data are presented as absolute frequencies and percentages. Survival curves were estimated by the Kaplan-Meier method and compared using the log-rank test. Univariable and multivariable Cox proportional hazards models were used to assess the association of predictors with mortality. Receiver-operator characteristics (ROC) curves were used to evaluate the predictive power of continuous parameters and risk scores and quantified by calculating the area under the curve (AUC). Optimum dichotomies of continuous variables were determined as the maximum of the log-rank statistics. The sensitivities achieved by the different models at a fixed specificity of 90% were compared by the McNemar test [23] . A stepwise multivariable Cox regression was performed separately in men and women to investigate whether sex 
Results
The whole study cohort (cohort A) consisted of 4141 patients (26.5% females), cohort B consisted of 2951 patients (24.5% females). A patient flow chart of the study is shown in Fig. 1 .
Effect of sex on mortality
Clinical characteristics of cohort A are shown in Table 1 . The median age was 62 and 70 years in male and female patients, respectively. Diabetes mellitus and hypertension were more prevalent in women than in men, while men were more frequently smokers and had more frequently a history of previous MI. LVEF did not significantly differ between male and female patients. Coronary angiography was performed in 99.9% of male and in 99.5% of female patients. The revascularization rate was significantly lower in women than in men (89.5% vs. 94.7%, p b 0.0001). There were no significant sex differences in the use of aspirin, β-blockers and statins. Female patients were significantly less often treated with ACE inhibitors but more frequently with diuretics.
Twenty-nine patients were lost to follow-up. Mortality curves for patients stratified by sex are shown in Fig. 2 . At 30 days, mortality rate was 9.3% in women and 6.1% in men (p b 0.0001). At 5 years, these rates were 25.4% and 17.3%, respectively (p b 0.001). When we restricted the latter analysis to survivors of the initial hospital stay, these rates were 17.6% and 12.0%, respectively (p b 0.0001).
Female sex was a significant predictor of the 30-day and 5year all-cause mortality in a univariable Cox analysis, with hazard ratios of 1.55 (1.22-1.98) and 1.53 (1.33-1.77), respectively (p b 0.001 for both). However, in multivariable models adjusted for age, female sex was no longer significantly associated with mortality (p = 0.188 and p = 0.103; Table 2 ).
Sex differences in the prediction of long-term outcome
The clinical characteristics of cohort B are shown in Table 3 . As in cohort A, women were older, were more frequently affected by diabetes and hypertension, and received revascularization treatment less frequently (92.0% vs. 96.4%, p b 0.0001).
There were marked sex differences in the AUC values of ROC curves as well as in the optimum dichotomies of investigated risk factors. For example, mean heart rate was a stronger mortality predictor in men than in women (AUC 0.66 vs. 0.61), and the optimum separation between survivors and non-survivors was achieved with a dichotomy of ≥ 71 beats per minute (bpm) in men and ≥ 85 bpm in women (see Fig. 3 ).
The sex-specific Cox regression models were not only different in dichotomies but also in the independent variables (Table 4 ). Moreover, the hazard ratios of some variables differed largely between models. For example, the absence of sinus rhythm was associated with a hazard ratio of 7.6 in female and of 3.2 in male patients.
ROC curves for the performance of both sex-specific and sex-neutral risk models in male and female patients and in the complete study cohort are shown in Fig. 4 . In women, the sex-specific model performed better than the sex-neutral model (AUC of 0.825 vs. 0.802, Fig. 4A ). At a specificity of 90%, sensitivity increased significantly from 33.9% of the sex-neutral model to 50.0% of the sex-specific model (p b 0.001). In men, the predictive power of the sex-specific model was practically identical with that of the sex-neutral model (AUC of 0.805 vs. 0.799; Fig. 4B ). In an analysis of the entire cohort, the performance of the sex-specific model was also only marginally better than that of the sex-neutral Table 5 . While a sex-specific model resulted in better positive and negative predictive values in women, these differences were almost absent in the overall cohort.
Discussion
The first aim of this study was to re-assess the mortality risk in contemporarily-treated MI patients of either sex. We found that 30-day mortality of female patients was 1.5-fold higher than that of male patients. The excess mortality of women in our cohort can be explained by their older age. After adjusting for age, sex was no longer a significant mortality predictor. Because of more advanced age at the time of MI, female patients have a greater disease burden (exemplified by a higher prevalence of diabetes, hypertension, and the absence of sinus rhythm; see Table 1 ).
Our data do not support the assumption that inadequate diagnostic efforts are responsible for the unfavorable outcome in post-MI women. In our population the percentage of coronary angiographies was high in both female and male patients.
Earlier observations [6] indicated that the higher mortality of female MI patients is caused by a lower revascularization rate. However, in that study, the overall revascularization rate was less than 10%, as compared to 93% in our cohort. In our study, we also observed a significantly lower revascularization rate in females (89.7% in males versus 84.2% in females). This may be explained by the higher prevalence of non-obstructive CAD in women observed in this and another study [7] . However, treatment was left to the discretion of the interventional cardiologist, and we cannot exclude that decisions for or against revascularization were also influenced by factors such as age or sex.
The second aim was to investigate whether the prediction of poor outcome in survivors of the acute phase of MI can be improved by sex-specific predictive models. To a certain extent, the prognostic power of several risk factors differed between male and female patients. Moreover, several optimum dichotomies differed markedly between men and women. These differences led to a sex-specific risk model, which in female patients performed better than a sex-neutral model. If applied to the whole cohort, the improvement in risk stratification by using sex-specific risk models was only marginal. However, this may be explained by the lower proportion of women in the complete cohort. We may thus conclude that risk prediction in women might benefit from sex-specific risk models.
Our study has also several limitations. Most importantly, because of higher prevalence of MI in men, the number of female patients in our study was more than 3 times lower than that of male patients. Consequently, the calculations applied to female patients had lower statistical power. The dichotomies and the models for the prediction of 5-year mortality were developed in the same cohort of patients to whom they were applied. This might have resulted in over-optimization. The true performance gain of a sex-specific model for female patients might thus be smaller than we estimated. 
